A Global In Vivo Drosophila RNAi Screen Identifies NOT3 as a Conserved Regulator of Heart Function  by Neely, G. Gregory et al.
ResourceA Global In Vivo Drosophila RNAi
Screen Identifies NOT3 as a
Conserved Regulator of Heart Function
G. Gregory Neely,1,16 Keiji Kuba,2,16,* Anthony Cammarato,3,16 Kazuya Isobe,2,4 Sabine Amann,1 Liyong Zhang,7
Mitsushige Murata,8 Lisa Elme´n,3 Vaijayanti Gupta,9 Suchir Arora,9 Rinku Sarangi,9 Debasis Dan,9 Susumu Fujisawa,2
Takako Usami,5 Cui-ping Xia,1 Alex C. Keene,10 Nakissa N. Alayari,3 Hiroyuki Yamakawa,8 Ulrich Elling,1 Christian Berger,1
Maria Novatchkova,1 Rubina Koglgruber,1 Keiichi Fukuda,8 Hiroshi Nishina,6 Mitsuaki Isobe,4 J. Andrew Pospisilik,1
Yumiko Imai,2 Arne Pfeufer,11,12 Andrew A. Hicks,13 Peter P. Pramstaller,13,14,15 Sai Subramaniam,9 Akinori Kimura,5
Karen Ocorr,3 Rolf Bodmer,3,* and Josef M. Penninger1,*
1Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences, Dr. Bohr Gasse 3-5, A-1030 Vienna, Austria
2Department of Biological Informatics and Experimental Therapeutics, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita
010-8543, Japan
3Development and Aging Program, Del E. Webb Neuroscience, Aging, and Stem Cell Research Center, Sanford-Burnham Medical Research
Institute, La Jolla, CA 92037, USA
4Department of Cardiology
5Department of Molecular Pathogenesis, Medical Research Institute
6Department of Developmental and Regenerative Biology, Medical Research Institute
Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8510, Japan
7Division of Cardiology, Toronto General Hospital, University Health Network, University of Toronto, Canada
8Department of Regenerative Medicine and Advanced Cardiac Therapeutics, Keio University School of Medicine, 160-8582 Tokyo, Japan
9Strand Life Sciences, 237 C V Raman Avenue, Rajmahal Vilas, 560024 Bangalore, India
10Biology Department, New York University, 100 Washington Square East, New York, NY 10003, USA
11Institute of Human Genetics, Technische Universita¨t Mu¨nchen, D-81675 Munich, Germany
12Institute of Human Genetics, Helmholtz Center Mu¨nchen, D-85764 Neuherberg, Germany
13Institute of Genetic Medicine, European Academy Bozen/Bolzano, 39100 Bolzano, Italy
14Department of Neurology, General Central Hospital, 39100 Bolzano, Italy
15Department of Neurology, University of Lu¨beck, 23538 Lu¨beck, Germany
16These authors contributed equally to this work
*Correspondence: kuba@med.akita-u.ac.jp (K.K.), rolf@burnham.org (R.B.), josef.penninger@imba.oeaw.ac.at (J.M.P.)
DOI 10.1016/j.cell.2010.02.023SUMMARY
Heart diseases are the most common causes of
morbidity and death in humans. Using cardiac-
specific RNAi-silencing in Drosophila, we knocked
down 7061 evolutionarily conserved genes under
conditions of stress. We present a first global road-
map of pathways potentially playing conserved roles
in the cardiovascular system. One critical pathway
identified was the CCR4-Not complex implicated in
transcriptional and posttranscriptional regulatory
mechanisms. Silencing of CCR4-Not components in
adult Drosophila resulted in myofibrillar disarray
and dilated cardiomyopathy. Heterozygous not3
knockout mice showed spontaneous impairment
of cardiac contractility and increased susceptibility
to heart failure. These heart defects were reversed
via inhibition of HDACs, suggesting a mechanistic
link to epigenetic chromatin remodeling. In humans,
we show that a common NOT3 SNP correlates
with altered cardiac QT intervals, a known cause142 Cell 141, 142–153, April 2, 2010 ª2010 Elsevier Inc.of potentially lethal ventricular tachyarrhythmias.
Thus, our functional genome-wide screen in
Drosophila can identify candidates that directly
translate into conserved mammalian genes involved
in heart function.
INTRODUCTION
Cardiovascular diseases are the most common cause of death in
North America and Europe (Yusuf et al., 2001) killing more than
860,000 people annually in the United States (A.H.A., 2005;
Lloyd-Jones et al., 2009). Moreover, 80 million people in the
United States are estimated to suffer from cardiovascular
diseases (A.H.A., 2005; Lloyd-Jones et al., 2009). Known or
associated causes of cardiovascular disease include diabetes
mellitus, inflammation, high cholesterol, hypertension, over-
weight and obesity, physical inactivity, or smoking (A.H.A.,
2005; Lloyd-Jones et al., 2009). Although there have been great
advances in the understanding of heart failure in recent decades
(Mudd and Kass, 2008), there is still a gap in understanding the
genetic causes and an unmet need for better therapies. In partic-
ular, the complex interplay of lifestyle, genetic susceptibilities,
Adult Heart
Defect
Adult 
Viable
Lethal
365 (4.6%) 490 (6.2%)
7116 (89.2%)
Temperature 
stress
s
lp
1
p
a
n
n
ie
r
M
e
f2
e
v
e
D
o
c
1
D
o
c
2
D
o
c
3
a
b
d
o
m
in
a
l 
A
z
fh
1
lb
l
tw
is
t
M
a
d
a
rm
a
d
il
lo
ti
n
m
a
n
H
a
n
d
H
1
5
0
1
2
3
4
5
Z
 S
c
o
r
e
D E
B
Prescreen
0 1 2 3 4 5 6 7
0
20
40
60
80
100
Days at 29
o
C
%
 
S
u
r
v
i
v
a
l
x
TinCΔ4-Gal4
Developmental
Lethal
Adult
Lethal
10 days
25
o
C
4 days
25
o
C
Fail
(mortality)
6 days
29
o
C
Pass
(survival)
Re-test lethals & “heart stress” hits (4x)
A
UAS-RNAi
(VDRC library)
C
0 1 2 3 4 5 6 7
0
20
40
60
80
100
LT50 = 6.19 +/- 0.09
Pass
Fail
Days at 29
o
C
%
 
S
u
r
v
i
v
a
l
Figure 1. Genome-wide Screen for
Conserved Heart Genes
(A) Schematic for screen setup. TinD4-Gal4,
a cardiac tissue specific driver, was used to drive
conserved UAS-RNAi hairpins in the developing
heart. Developmental lethality and baseline adult
viability was scored. Viable adult flies were
then given a heart stress (continued exposure to
29C) and survival was scored on day 6. Fly lines
showing a potential developmental or heart func-
tion phenotype were then retested to confirm the
candidate gene.
(B) Eighty randomly selected UAS-RNAi lines were
crossed to TinCD4-Gal4 and evaluated for adult
lethality after an increase in ambient temperature
as a cardiac stressor. Lines were either viable
(black) or died starting around day 3. Data from
individual lines are shown as percent survival on
the indicated days.
(C) Mean responses from viable and failing (death
after exposure to 29C) flies revealed an average
lethal time at which 50% of failing flies died
(LT50) of 6.19 days.
(D) Efficacy of TinCD4-Gal4 x UAS-RNAi lines to
knock down transcription factors known to play
a role in heart formation.
(E) With this system, a genome-wide screen was
performed to search for conserved candidate
genes for adult heart function under conditions of
cardiac stress; 4.6% TinCD4-Gal4 x UAS-RNAi
lines were developmental lethal. Among the
7971 viable lines, 490 transformant lines exhibited
significantly increased death (Z score >3, deter-
mined on day 6 after shifting the ambient temper-
ature to 29C).
See also Figure S1 and Tables S1 and S2.diseases, and aging have made it difficult to understand the
underlying pathogenic principles (Yusuf et al., 2001). In addition
to large-scale genetic mapping and phenotyping in humans
(Gordon et al., 1977; Morita et al., 2005; Nabel, 2003), a genetic
dissection of the cardiovascular system in less complex model
organisms would greatly facilitate the understanding of basic
controls of cardiac physiology and mechanisms of disease.
Multiple proteins that control contraction in cardiomyocytes
are highly conserved between species. For instance, the fly
heart is capable of spontaneous rhythmic activity required for
the circulation of hemolymph, and the same genes control
heart rhythm in humans and flies (Ocorr et al., 2007a). In aging
flies, the heartbeat becomes irregular with increased episodes
of arrhythmias (Ocorr et al., 2007b), reminiscent of increased
atrial fibrillation and heart failure in older humans (Lakatta
and Levy, 2003). Moreover, genes involved in specification
and differentiation of the heart are also conserved betweenCell 141, 142–Drosophila and mammals (reviewed in
Bodmer, 1995; Cripps and Olson, 2002;
Ocorr et al., 2007a). Mutations in sub-
units of repolarizing voltage gated potas-
sium channels IKr (eag, KCNH2) and IKs
(kvLQT1, KCNQ1) perturb heart function
in Drosophila and in vertebrates cancause long QT syndrome (Ocorr et al., 2007b; Sanguinetti and
Tristani-Firouzi, 2006). Moreover, the sarco-endoplasmic retic-
ulum Ca2+-ATPase (serca2a, ATP2A2) and the Ca2+-channel
Cacophony control heart function also in Drosophila (Ray and
Dowse, 2005; Sanyal et al., 2006). Thus, Drosophila has become
a powerful genetic model system to identify conserved genes
involved in heart function.
RESULTS
A Drosophila High-Throughput Assay to Identify
Candidate Heart Genes
To identify candidate genes for heart development and heart
function (Figure 1A), we used cardiac tissue-specific RNA
interference (RNAi) silencing of all genes that we identified as
showing possible conservation between mammalian species
and Drosophila melanogaster (Table S1, part A, available online).153, April 2, 2010 ª2010 Elsevier Inc. 143
TinCD4-Gal4 specifically drives expression in cardioblasts (Lo
and Frasch, 2001) and has been previously used to study genes
involved in heart function of the adult fly (Qian et al., 2008).
Because RNAi-mediated downregulation of gene expression in
many cases permits the circumvention of lethality commonly
associated with classical mutations (Dietzl et al., 2007), cardiac
tissue-specific TinCD4-Gal4 RNAi-mediated gene silencing
therefore allowed us to assay the functional roles of the respec-
tive target genes in adult flies. Since elevated ambient tempera-
ture results in an increase in Drosophila heart rate (Paternostro
et al., 2001; Ray and Dowse, 2005), we combined cardiac
tissue-specific RNAi knockdown with an increased ambient
temperature to reveal cardiac phenotypes under conditions of
stress. Elevated temperature also enhances the activity of the
UAS/GAL4 system, without affecting survival within the time-
frame of the experiment (Figure S1A).
To evaluate the efficacy of this experimental setup (Figure 1A),
we performed a prescreen with 80 randomly selected genes
that were targeted by TinCD4-Gal4 RNAi (Table S1, part B).
Whereas 10% of these TinCD4-Gal4 RNAi lines started to die
at the increased ambient temperature, the vast majority survived
for more than 7 days (Figure 1B). From these pilot experiments,
we calculated an average time of 6.19 days at which 50% of flies
among the susceptible lines had died (lethal time 50 [LT50])
(Figure 1C). Thus, our large-scale genome-wide screen was
carried out at 29C and lethality was recorded for each line at
day 6. As a control, TinCD4-Gal4 RNAi knockdown of known
cardiogenic transcription factors resulted in viable lines at
25C (data not shown), but a shift to 29C resulted in increased
death of nearly half of the transcription factor RNAi lines tested,
including Tinman, Hand, and H15 (neuromancer-1/Tbx20) (Fig-
ure 1D). Cardiac knockdown of pannier/Gata4 and the Doc
genes (Tbx5/6) did not cause premature lethality at 29C, even
though they are known to contribute to adult heart function
(Qian and Bodmer, 2009; Qian et al., 2008). As negative controls,
we used RNAi lines targeting eve and zfh-1, which are not
expressed in the myocardium targeted by TinCD4-Gal4 (Fig-
ure 1D). Thus, we have set up a model system that allows for
efficient high-throughput screening and has the capacity to
pick up known heart genes.
A Genome-wide In Vivo Fly RNAi Screen
for Conserved Genes
In total we screened 8417 transgenic RNAi lines corresponding
to 7061 conserved genes for potential developmental and adult
heart functional defects (Table S1, part C). We only included
7971 lines representing 6751 genes that fit the previously defined
criteria of specificity (Dietzl et al., 2007) for further analyses, i.e.,
only lines with an S19 scoreR0.8 and having six or fewer CAN
repeats were considered specific (Table S1, part D). Progeny
of each RNAi line crossed to TinCD4-Gal4 were first monitored
for viability (reared at 25C). Among these 7971 RNAi lines, 365
lines resulted in lethality (Figure 1E and Table S1, part E), indi-
cating that many of these genes function in heart development.
Developmental lethality was further staged as lethal (embryonic
lethal or we never observed any offspring), larval lethal, pupal
lethal, or early adult (within 4 days after eclosion) lethal (Table
S1, part F).144 Cell 141, 142–153, April 2, 2010 ª2010 Elsevier Inc.To identify candidate genes for adult heart function, we
assayed 7804 adult TinCD4-Gal4 RNAi progeny (Dietzl et al.,
2007) for survival after shifting the flies to 29C (Figures S1B–
S1D). To categorize our hits from the screen, we used the
Z score, which is a measure of the distance in standard devia-
tions of a sample from the mean. All RNAi lines with a Z score
of 2 in the primary screen were tested on average 4.18 indepen-
dent times (an average of 90 flies per genotype) using in some
cases second RNAi transformants to control for transgenic
insertion effects and second independent RNAi hairpins to
target a different region of the gene (Table S2). After repeated
screening, we identified 498 genes that passed the more strin-
gent Z score of 3 (Figure 1E and Table S2), indicating that these
hits exhibit a death score of three standard deviations from
the mean. Using gene ontology (GO) annotations, our candidate
hits were classified according to their predicted biological
processes (BP), molecular functions (MF), and cellular compo-
nents (CC). Of the classified genes, those involved in signaling,
ion transporter activity, metabolism and mitochondrial structure,
development and morphogenesis, transcriptional regulation, or
nucleic acid binding were highly represented among the entire
data set (Figure S2 and Table S4, part A). To remove any artificial
bias in the gene list created by the ad hoc Z score cutoff >3, we
performed a gene set analysis (GSA) to confirm enrichment of
selected GO terms (Table S4, part B). In addition, 121 candidate
heart genes had no annotated function by GO. With panther
(http://www.pantherdb.org/), we were able to functionally anno-
tate 116 of these genes (Table S4, part C).
Given that the RNAi library screened is known to generate
a level of false negative phenotypes because of inefficient
targeting of genes to levels required to reveal phenotypes (Dietzl
et al., 2007), and based on the assumption that our candidate
heart hits perform some of their functions in protein complexes,
we next identified first-degree binding partners (Table S4,
part D). Using this list of primary heart hits and their binding
partners, we performed fly KEGG pathway analyses. Moreover,
we included developmental lethal hits to generate a global inter-
action network. KEGG analyses showed enrichment of multiple
pathways, such as mTOR signaling and PI3K/AKT, amino
acid metabolism, JAK-STAT signaling, ErbB signaling, the Wnt,
Notch, hedgehog, or TGFb pathways, protein degradation,
VEGF signaling, DNA repair, and calcium homeostasis (Table
S3 and Table S4, part E). Besides the identification of multiple
known genes, our screen has also revealed hundreds of candi-
date genes and pathways that have not been previously associ-
ated with heart function.
A Global View of Heart Function
To extend our Drosophila results to mammalian systems, we
used the power of data mining and bioinformatics at a global
systems level. Potential mouse and human orthologs of our
candidate heart screen hits were evaluated for GO enrichment.
The GO analyses of the human and mouse orthologs showed
marked enrichment of genes involved in PIP3 and calcium
signaling, ion transporter activity, metabolism, development,
fatty acid metabolism, and muscle contraction (Table S4, part F).
We next performed KEGG pathway as well as Broad Institute
C2 gene set analysis on the mouse and human orthologs and
Figure 2. A Global Network of Heart Function
The systems network includes data from the significantly enriched Drosophila KEGG and mouse and human KEGG and C2 data sets. Pathways and gene sets
from the same biological processes were grouped into common functional categories. Orange nodes represent statistically enriched functional categories of
pathways, red nodes represent direct primary fly RNAi hits, green nodes represent their first degree binding partners, and blue nodes indicate genes that
were scored as developmentally lethal in our Drosophila heart screen. Lines indicate associations of the genes to the appropriate functional category. All
KEGG pathways and selected C2 gene sets have been represented in the systems map. See also Tables S3, S4, and S5.their first-degree binding partners. Based on the mammalian
KEGG (Table S4, part E) and C2 (Table S4, part G) analyses,
we found significant enrichment for gene sets involved in
signaling, metabolism, ion channels, inflammation, aging, and
transcription.
To generate a network map that includes our functional data
in Drosophila, their human and mouse orthologs, and first-
degree binding partners, we combined KEGG pathways from
Drosophila, mouse, and human with relevant gene sets from
the Broad Institute C2 annotations (Table S4). A combined
systems map and the interactions between the individual genes
in the indicated nodes are shown in Figure 2 and Table S4,
part H. A systems map using only direct screening hits was
also generated, yielding a comparable network map (Table S3).
Importantly, by using this network approach, we identified
multiple pathways known to play key roles in heart function
and cardiovascular disease. For instance, we found significant
enrichment in NFAT transcription, AKT activation, and PI3K
signaling, calcium signaling and muscle contraction, GPCR-
and cAMP signaling, ion channels and proton-transporting
ATPase complexes, and transcription. We also found associa-tions with the renin-angiotensin system, a key pathway involved
in cardiovascular function in humans (Figure 2 and Table S4,
part H). In support of our network approach, advanced data
mining revealed that 171 of our primary fly hits and their first-
degree binding partners corresponded to mouse knockouts
with known cardiovascular phenotypes (Table S5). Thus, our
genome-wide screen for candidate heart genes and in silico
analyses provides a first attempt at a global roadmap of essential
molecular components and key pathways potentially involved in
heart function and cardiac failure.
RNAi Silencing of not3 and UBC4 Results in Dilated
Cardiomyopathy in Drosophila
One of the pathways we found in our global network analysis was
the CCR4-Not complex (Figure 2 and Table S3). Intriguingly,
among the eight members of this complex assayed, we hit the
subunits not1, not3 (not3/5 in fly), not4, UBC4, and Hsp83
(Figure 3A). In addition, the subunits not2 and CG8759 were
‘‘weak’’ hits (Figure 3A). The CCR4-Not complex was first iden-
tified in yeast (Denis, 1984) and is highly conserved in evolution
(Albert et al., 2000). Components of the CCR4-Not complexCell 141, 142–153, April 2, 2010 ª2010 Elsevier Inc. 145
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Figure 3. The CCR4-Not Complex Is a
Central Regulator of Adult Heart Function,
and Loss of not3 Results in Dilated Cardio-
myopathy in Drosophila
(A) Mean Z scores for TinCD4-Gal4 x UAS-RNAi
lines targeting the indicated members of the fly
CCR4-Not complex. A negative control (w1118
[isogenic to the RNAi library] X TinD4-Gal4) and
the positive control Tinman RNAi line are shown.
(B) not1, not3, and UBC4 are essential for proper
adult heart function in both Tinman- and Hand-
expressing cells. Data are shown as mean ±
SEM for at least three replicates. RNAi1 and
RNAi2 indicate different transgenic hairpins tar-
geting not3 . *p < 0.05, **p < 0.01 by ANOVA.
(C) One-week-old adult flies with Hand-Gal4
driving not3 or UBC4 cardiac-specific knockdown
exhibit impaired heart function. M modes provide
traces of the heart contractions to document the
movements in a 1 pixel wide region of the heart
tube over time. HandG4/+ control are the progeny
of Hand-Gal4 crossed to w1118. Hand>Not3
complex flies are the progeny of Hand-Gal4
crossed to either UAS-not3-RNAi (1 or 2) or
to UAS-UBC4-RNAi lines. Fly heart analysis was
performed with a MatLab-based image analysis
program (Fink et al., 2009; Ocorr et al., 2007b).
M modes of the RNAi knockdown hearts reveal
dilated diastolic and systolic diameters (double-
headed red arrows) and reduced shortening
properties (difference between diameters) when
compared to M modes of control hearts. Each
trace represents a 5 s recording.
(D–G) Not3 or UBC4 heart-specific knockdown
perturbs several indices of cardiac performance.
Progeny of Hand-Gal4 crossed to two different
UAS-not3-RNAi lines or an UAS-UBC4-RNAi line
(experimental) and w1118 crossed to UAS-RNAi
or Hand-Gal4 driver (controls) were used for
these experiments as in (C). not3 and UBC4
knockdown led to significantly wider diastolic (D)
and systolic (E) diameters, and as a result signifi-
cantly depressed (F) fractional shortening in all
experimental lines relative to controls. not3
knockdown trended toward a slight lengthening
in the heart period (time between consecutive dia-
stolic intervals), whileUBC4 knockdown led to a significant increase in heart period (G). Mean values ±SEM are shown for each group (n = 29–40). Unpaired t tests
were performed between each Hand-Gal4>UAS-RNAi and each corresponding UAS-RNAi/+ control (progeny of w1118 crossed to UAS-RNAi line). Additionally,
one-way ANOVAs with Bonferroni multiple comparison tests revealed no significant differences between the HandG4/+ control and allUAS-RNAi/+ control lines,
for any cardiac parameter measured.
*p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S3 and Movie S1.have not yet been associated with cardiovascular function. We
therefore retested components of this pathway using TinCD4-
Gal4-driven knockdown in the heart, which confirmed the
phenotype (Figure 3B). Moreover, use of a second heart driver,
Hand-Gal4, which is expressed with high specificity in myocar-
dial and pericardial cells throughout development and in the
adult fly heart (Han and Olson, 2005), showed that silencing of
not1, not3, and UBC4 resulted in early death when adult flies
were shifted to 29C (Figure 3B).
Since not3 RNAi gave a strong phenotype with two different
UAS-RNAi lines (Figure 3B), we focused on the CCR4-Not
component not3. Cardiac-specific knockdown of not3 with two146 Cell 141, 142–153, April 2, 2010 ª2010 Elsevier Inc.different RNAi lines (Hand>not3-RNAi: progeny from Hand-Gal4
crossed toUAS-not3-RNAi) significantly increased both diastolic
and systolic diameters and resulted in reduced systolic fractional
shortening relative to control flies (Figures 3C–3F and Movie S1).
Hearts with cardiac not3 knockdown also showed slight
increases in heart periods (Figure 3G); however, this was not
statistically significant. Fluorescent microscopy revealed that
not3 RNAi lines exhibit marked myofibrillar disarray, especially
in the conical chamber (Figures 4A–4D). Heart-restricted not3-
RNAi-mediated knockdown was confirmed by qRT-PCR
(Figure S3). In addition, we observed transcriptional downregula-
tion of the Sarcoplasmic/endoplasmic reticulum calcium ATPase
Figure 4. not3 and UBC4 Cardiac-Specific
RNAi Knockdown Substantially Perturb
Myofibrillar Organization and Content
(A) Alexa584-phalloidin staining of control
Drosophila cardiac tubes reveals typical spiraling
myofibrillar arrangements within the cardiomyo-
cytes. The fibers, especially those in the conical
chamber, located anteriorly, are densely packed
with F-actin.
(B–D) Relative to control hearts, not3 or UBC4
RNAi knockdown severely disrupts myofibrillar
organization and leads to an apparent loss of
myofilaments as noted by large gaps in F-actin
staining (*) as well as by a lack of myosin heavy
chain transcripts (Figure S3F).
(A0–D0) Enlarged images of the conical chambers
from (A)–(D), respectively, which illustrate the
high degree of myofibrillar disarray and large
gaps in F-actin staining within the cardiomyocytes
of not3 and UBC4 RNAi knockdown hearts. Orig-
inal images were taken at 103 magnification
with a Zeiss Imager Z1 fluorescent microscope.(Serca2a, ATP2A2), myosin heavy chain (mhc, MYH7), and the
potassium channel KCNQ (kcnq1, KCNQ1) (Figure S3) involved
in heart rhythm control. Cardiac-specific knockdown of not3
increased the number of flies exhibiting contractile irregularities
(Figures S3H and S3I), a finding similar to what is seen in response
to cardiac-specific knockdown of the KCNQ K+ channel
(Figure S3I) and what has been reported for KCNQ mutant flies
(Ocorr et al., 2007b). Of note, a not3 P element mutant was devel-
opmentally lethal, exhibiting a late stage defect in embryonic
heart tube organization, which could be rescued by P element
excision (Figure S3C).
The CCR4-Not complex component UBC4 was also a major
hit identified by our heart screen. Moreover, UBC4 expression
was reduced after not3 knockdown (Figure S3B). Hand-Gal4>
UAS-UBC4-RNAi flies also exhibited significantly longer heart
periods and showed dramatically altered diastolic and systolic
diameters and reduced fractional shortening relative to control
hearts (Figures 3C–3G). Fluorescent imaging again revealed
severe myofibrillar disarray (Figure 4D) that was strikingly similar
to that observed in not3 knockdown hearts. Further, we
observed similar structural and functional phenotypes in not1
cardiac-specific knockdown flies (A.C., G.N., J.P., and R.B.,
unpublished data). Thus, knockdown of different components
of the CCR4-Not complex result in abnormal heart structure
and severely impaired cardiac function indicative of dilated
cardiomyopathy.Cell 141, 142–Functional Assessment
of Additional Drosophila Heart Hits
To extend our confirmations beyond
the CCR4-Not complex, we assayed
heart function in adult flies with heart-
specific knockdown of four additional
candidates identified in our heart screen
(Figure S3). One candidate heart gene
tested was CG1216 (Mrityu), which
encodes a mesoderm-expressed BTB-POZ domain-containing protein (Rusconi and Challa, 2007).
Cardiac knockdown of CG1216 resulted in a significant increase
in systolic diameter. Another candidate heart gene, CG8933
(extradenticle), encodes a PBX-family transcription factor.
Cardiac knockdown of CG8933 resulted in increased systolic
diameter and reduced fractional shortening. Cardiac knockdown
of CG33261 (Trithorax-like) resulted in significantly altered
diastolic and systolic diameters as well as impaired fractional
shortening. Finally, knockdown of CG7371, which encodes
a Vps52 domain-containing protein predicted to participate in
Golgi trafficking, resulted in a marked increase in heart period
and affected the diastolic diameter. These data further dem-
onstrate that our screen indeed has the capacity to identify
novel factors involved in and required for normal adult heart
function.
Generation of not3 Knockout Mice
We next tested whether our data on Drosophila can be directly
translated into a mammalian species. The mouse and human
NOT3 proteins (official gene name Cnot3) share 60% identity
with the Drosophila not3 ortholog. Expression of human and
mouse not3 messenger RNA (mRNA) transcripts can be found
in the majority of tissues analyzed. Although not3 is evolutionarily
conserved from yeast to mammals, essentially nothing is known
about the in vivo role of mammalian not3. We therefore gener-
ated not3 knockout mice.153, April 2, 2010 ª2010 Elsevier Inc. 147
We disrupted the not3 gene in murine embryonic stem cells
(ESCs) using a targeting vector in which nucleotides encompass-
ing exons 2 through 9 are deleted (Figure 5A and Figure S4A).
Both not3+/ male and not3+/ female mice are viable and exhibit
normal fertility. We never obtained viable not3/ newborn mice,
indicating that loss of not3 results in embryonic lethality. We
staged embryonic development but failed to recover not3 null
embryos from placental implantations (Figures S4B and S4C).
We therefore assayed early embryogenesis and observed that
not3/ blastocysts can develop. These mutant blastocysts
have a normal appearance (Figure S4D), occur at Mendelian
frequencies (Figures S4E and S4F), and express key markers of
early embryonic differentiation at normal levels (Figure S4G).
not3 mRNA transcripts and NOT3 protein were undetectable in
not3/ blastocysts by RT-PCR and immunostaining (Figures
S4F and S4G). In not3+/+ and not3/ epiblast cultures
(Figure S4H), trophoblast cells started to spread and supported
the outgrowths of the inner cell mass (ICM). While the ICM of
not3+/+ blastocysts continued to grow, not3/ ICM cells ex-
hibited a severe outgrowth defect. Thus, complete loss of mouse
not3 results in early embryonic death at the implantation stage.
not3 Haploinsufficiency Results
in Impaired Heart Function
We speculated that similar to RNAi-mediated downregulation of
not3 in Drosophila, not3 haploinsufficiency might also reveal a
role in mammalian heart function. In not3 heterozygote mice,
not3 expression is indeed downregulated in the heart (Fig-
ure 5B). We failed to observe overt structural changes in the
hearts of not3+/ mice. However, both male and female not3
haploinsufficient mice exhibited a reduction in cardiac contrac-
tility as determined by decreased left ventricle fractional short-
ening and increased left ventricular diameter in systole (Figures
5C and 5D).
To address whether the defects in cardiac function are
intrinsic to the heart per se or whether the observed impairment
of contractility was secondary because of haploinsufficiency of
not3 in other tissues, we subjected explanted hearts from wild-
type and not3+/ littermate mice to Langendorff perfusion,
assessing ex vivo heart function (Joza et al., 2005). When isopro-
terenol was used to activate b-adrenergic receptors, not3+/
hearts exhibited severe contractile abnormalities as defined by
impaired generation of left ventricular pressure (LVP) (Figure 5E
and Figure S5A). Hemodynamic measurements confirmed that
all functional heart parameters such as dP/dTmax or dP/dTmin,
indicative of generated contractile pressure, were markedly
reduced in not3+/ hearts (data not shown). Moreover, when
explanted hearts were electrically stimulated, not3+/ hearts
exhibited a striking defect in contractility (Figure 5F). Thus,
downregulation of not3 expression in not3 haploinsufficient
mice results in an intrinsic impairment in heart function.
Yeast strains mutant for components of the CCR4-Not
complex, including not3, display reduced acetylation levels of
lysine residues on histone tails (e.g., H3K9) (Peng et al., 2008)
and/or reduced trimethylation of H3K4 (Laribee et al., 2007).
H3K9 acetylation and H3K4 trimethylation are indicative of
transcriptionally active states of chromatin. Moreover, promoter
regions of NOT3 target genes were shown to recruit trimethy-148 Cell 141, 142–153, April 2, 2010 ª2010 Elsevier Inc.lated H3K4 in mouse ESCs (Hu et al., 2009), suggesting that
NOT3 may regulate chromatin modifications. Our gene expres-
sion and bioinformatic analyses of mouse not3 knockout cells
revealed that histone deacetylases (HDACs) and mRNA metab-
olisms are localized central in gene networks (K.K., unpublished
data). We therefore assessed the state of histone modifications
in hearts from not3+/ mice. Histone extracts of whole hearts
from not3 haploinsufficient mice showed a slight but significant
reduction in active histone marks such as acetylation of H3K9
and trimethylation of H3K4 (Figures 5G and 5H and Figure S5).
H3K27 trimethylation was not changed (Figure 5I and Figure S5).
Treatment of not3+/ hearts with the HDAC inhibitor VPA
restored the reduced acetylation of H3K9 and H3K4 trimethyla-
tion to that of wild-type levels (Figures 5G–5I and Figure S5).
Most importantly, administration of HDAC inhibitors rescued
the impairment in heart function in not3+/ mice; i.e., ex vivo
heart functions of VPA treated mice were similar to control
mice in response to both isoproterenol (Figure 5J) and electrical
stimulation (Figure 5K). These data were confirmed with TSA, a
second HDAC inhibitor (Figures S5H and S5I). Together, these
data show that not3+/ mice exhibit a spontaneous and intrinsic
defect in cardiac function that can be rescued with HDAC
inhibitors.
not3+/ Mice Develop Severe Cardiomyopathy
in Response to Cardiac Stress
We next exposed control and not3+/ littermates to chronic pres-
sure overload by surgical constriction of the aorta (transverse
aortic constriction, TAC). Three weeks after TAC, heart weight/
body weight ratios (HW/BW) increased in both not3+/+ and
not3+/ mice, although this increase was significantly larger in
the not3+/ mice (Figure 6A). Cardiac hypertrophy was also
seen by histology (Figure 6D and Figure S6A). Aortic banding of
not3+/ mice resulted in severe heart failure characterized by
decreased fractional shortening (Figure 6B) and a dilation of the
left ventrical as determined by echocardiography (Figure 6C). In
addition, not3+/ mice develop severe cardiac fibrosis after
TAC, as shown by Masson-trichrome staining of hearts 3 weeks
after TAC (Figure 6D and Figure S6B). Thus,not3+/mice develop
severe symptoms of heart failure in response to cardiac stress.
We next assessed whether HDAC inhibitors can also rescue
stress-induced heart failure. HDAC inhibitor treatment could
indeed block the augmented loss of cardiac function observed
in not3+/ mice after TAC (Figures 7A and 7B). In vivo treatment
of not3+/ mice with HDAC inhibitors also blocked the exagger-
ated induction of heart failure markers such as ANF (Figure S6C)
and bMyhc (Figure S6D). Moreover, treatment with an HDAC
inhibitor restored the observed histone alterations in not3+/
mice to that of wild-type littermates (Figure 7C and Figures
S6E and S6F). Thus, not3 haploinsufficiency results in exag-
gerated heart failure that can be rescued by HDAC inhibition
in vivo.
A Common Genomic Variant in the NOT3 Promoter
Correlates with Cardiac Repolarization Duration
in Humans
Using an in silico search to identify NOT3 target genes, we found
that NOT3 has been shown to bind to the Kcnq1 promoter in
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Figure 5. not3+/Mice Exhibit Reduced Heart Contractility, Ex Vivo Function, and Histone Modifications that Can Be Rescued by Treatment
with HDAC Inhibitors
(A) Gene targeting strategy. Exons 2 to 9 of the not3 gene (official symbol cnot3) were replaced with a PGK-Neo cassette by homologous recombination in A9
ESCs. The wild-type allele, targeting vector, mutant allele, and PGK-Neo and DTH selection cassettes are shown. Blue boxes indicate exons.
(B) Real-time PCR analyses for not3 mRNA expression in 3-month-old wild-type and not3+/– hearts. Values were normalized to gapdh mRNA expression. n = 6
mice per group.
(C) not3+/– mice display a significant reduction in percent fractional shortening at 4 months of age, which became more pronounced with age. n = 6–8 mice per
group. Fractional shortening was determined by echocardiography.
(D) Representative M mode echocardiography for wild-type and not3+/– mice at 8 months of age.
(E) Left ventricular pressure (LVP) measurements in isolated ex vivo not3+/– and not3+/+ hearts under isoproterenol perfusion. not3+/– hearts from 4-month-old
mice showed impaired contractile responses to different doses of isoproterenol perfusion in the retrograde Langendorff mode as compared to age-matched
controls.
(F) Impaired contractile response of ex vivo not3+/– hearts to electrical field stimulation (EFS) compared with littermate not3+/+ hearts. Representative data for left
ventricular pressure (LVP) at 20 V stimulation are shown.
(G–I) H3K9 acetylation (H3K9ac) (G), H3K4 trimethylation (H3K4me3) (H), and H3K27 trimethylation (H3K27me3) (I) levels were analyzed by western blot for acid-
extracted histones from whole heart ventricles of wild-type and not3+/– mice treated with vehicle or VPA (0.71% w/v in drinking water for 1 week) Band intensities
were normalized to total H3 levels.
(J and K) Treatment (1 week) with the HDAC inhibitor VPA rescue impaired ex vivo heart contractility of not3+/– hearts to isoproterenol (100 nM) perfusion or 25 V
EFS.
All values are mean ± SEM. *p < 0.05; **p < 0.01. n = 5–12 per group. See also Figures S4 and S5.
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Figure 6. Not3+/ Mice Exhibit Severe Heart
Failure in Response to Pressure Overload
(A) Heart weight to body weight ratios (HW/BW) in not3+/–
and not3+/+ littermate mice 3 weeks after transverse
aortic constriction (TAC). Animals receiving sham surgery
are shown as controls.
(B and C) Echocardiography of male not3+/– and wild-type
littermates 3 weeks after TAC.not3+/–mice with TAC show
decreased percent fractional shortening (%FS) (B) and
increased left ventricular diameter in systolic phase
(LVESD) (C) compared with not3+/+ mice that received
TAC. All values are mean ± SEM. *p < 0.05; **p < 0.01.
(D) Representative sections of not3+/+ and not3+/– hearts
analyzed 3 weeks after sham or TAC surgery. Masson-
trichrome stainings are shown to visualize collagen
deposits indicative of fibrotic changes. Note the severe
cardiac hypertrophy and ventricular dilation in not3+/
mice after TAC.ESCs (Hu et al., 2009). Kcnq1 encodes the a subunit of the repo-
larizing voltage gated potassium channel IKs, mutations in which
are the most common cause of long-QT syndrome (LQT1) in
humans (Wang et al., 1996). Abnormalities of cardiac repolariza-
tion, measured as alterations in QT interval, predispose to
sudden cardiac death in humans (Moss and Kass, 2005). Indeed,
while sham-operated not3+/ mice exhibit a subtle reduction in
cardiac Kcnq1 expression, this decrease was pronounced
after TAC (Figure 7D). Reduced Kcnq1 expression was rescued
after HDAC inhibitor treatment. Also, for Kcne1, the b subunit
of IKs, we observed a TAC-inducible and HDAC-sensitive defect
in expression in not3+/ hearts (Figure 7E). In fly not3-RNAi
hearts, KCNQ expression is also reduced (Figure S3D), and
these flies exhibit cardiac contractile irregularities (Figures S3H
and S3I).
Recently, two consortia have published genome-wide associ-
ation studies (GWAS) for QT interval, QT-Interval and Sudden
Cardiac Death (QTSCD) (Pfeufer et al., 2009) and Genetics
of QT-Interval (QTGEN) (Newton-Cheh et al., 2009). One of the
12 identified genomic regions contains the NOT1 gene, which
we also found as a hit in our Drosophila screen (Figures 3A
and 3B). Because of the stringent requirements to achieve150 Cell 141, 142–153, April 2, 2010 ª2010 Elsevier Inc.a genome-wide significance threshold of
p < 53 108 (Dudbridge and Gusnanto, 2008),
many genuinely associated alleles will be
missed because of both a failure to exceed
this statistical threshold and the absence of
functional confirmatory data for genes within
loci of interest. We therefore evaluated whether
common variants in and near the human NOT3
locus are also associated with alterations in QT
interval. Intriguingly, SNP rs36643 (chromo-
some 19: 59.3 Mb), located in the promoter
region 969 base pairs upstream from the
NOT3 transcriptional start site (924 bases
upstream of the TATA box), is significantly
associated with QT interval in the QTSCD
data set (Figure 7F). Patients carrying the
common T allele (minor allele frequency =0.65) showed a dose-dependent increase in QT interval
(ES = +1.03 ± 0.29 ms QT interval per copy of T allele, p =
3.66E04) (Figure 7G). Of note, similar to adult kcnq1 mutant
mice (Nerbonne, 2004), we did not observe an increased QT
interval in not3 heterozygous mice (except for one mouse with
arrhythmia, K.K., M.M., H.Y., and K.F., unpublished data).
Thus, our genome-wide screening data for death in flies can
be used to identify candidate variants in humans that predispose
individuals to heart disease, i.e., in the case of NOT3 to
arrhythmia and sudden death.
DISCUSSION
Here, we present the first in vivo RNAi adult heart screen in
Drosophila assaying conserved genes. Using functional imag-
ing, we were able to observe cardiac defects in all flies with
heart-specific knockdown of candidate genes evaluated to
date. Our experimental approach to screen for conserved heart
genes in Drosophila in concert with advanced bioinformatics
has the potency to reveal human and mouse genes involved
in heart function and heart disease. Moreover, we uncovered
a plethora of additional genes, a large proportion of which had
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Figure 7. not3 Is a Conserved Regulator of
Heart Function
(A and B) Rescue of severe heart failure in TAC
not3+/– hearts by the HDAC inhibitor VPA. One
day after TAC or sham surgery, the mice received
treatment with vehicle or VPA (0.71% w/v in
drinking water) for 6 weeks. Representative M
mode echocardiography (A) and percent FS (B) in
not3+/– and not3+/+ littermate mice 6 weeks
after TAC or sham surgery with or without VPA
treatment are shown. Values are mean ± SEM.
*p < 0.05.
(C) Reduced H3K9 acetylation (H3K9ac) and H3K4
trimethylation (H3K4me3) levels were rescued
by VPA treatment. Acid-extracted histones from
the hearts 6 weeks after TAC surgery were
immunoblotted with antibodies for H3K9ac and
H3K4me3. H3 is shown as a loading control.
(D and E) Real-time PCR analyses for the QT
interval-associated potassium channel genes
Kcnq1 and Kcne1. Total RNA was isolated from
hearts 6 weeks after TAC or sham surgery with
or without VPA treatment, and Kcnq1 and Kcne1
mRNA levels were measured and normalized to
18S mRNA. Data are shown as fold changes
compared to not3+/+ mice for each treatment
group. Values are mean ± SEM. *p < 0.05; **p <
0.01. n = 5–10 per group.
(F) Regional visualization of the association signal
between common variants in the NOT3 region
and the adjusted QT interval (QTc). SNP rs36643
in the 50 region of NOT3 (969 bp from the tran-
scription start and 924 bp from the TATA box)
showed a significant regional association
(p = 0.000366).
(G) Association between the T allele of SNP
rs36643 and a prolongation of QTc. * p < 0.0005
from linear regression with inverse variance
weighting using an additive genetic model. Data
are derived from a meta-analysis of genome-
wide association scans in several populations
(Pfeufer et al., 2009).
See also Figure S6.completely unknown functions until now. Future experiments are
required to test whether our candidate genes indeed control
cardiac development, regulate adult heart function, and/or
influence the outcome of heart failure in response to cardiac
stress.
One pathway we identified was the CCR4-Not complex.
Functional heart analyses in Drosophila confirmed that RNAi-
mediated silencing of the CCR4-Not components not3 and
UBC4 resulted in a severe impairment of cardiac function that
resembles dilated cardiomyopathy in experimental mouse
models and human patients. To provide a first proof of principle
that our fly hits can indeed have similar functions in the more
complex mammalian heart, we generated knockout mice for
a component of the CCR4-Not complex. not3 haploinsufficient
mice develop spontaneous impairment of heart function andsevere heart failure after aortic banding. Mechanistically, not3
downregulation results in a defect in active histone marks and
cardiac defects observed in not3+/ mice could be rescued by
treatment with HDAC inhibitors. Besides regulating transcrip-
tionally active states of chromatin (Hu et al., 2009; Jayne et al.,
2006; Laribee et al., 2007; Peng et al., 2008), the CCR4-Not
complex has also been implicated in RNA deadenylation (Tucker
et al., 2001) and microRNA-mediated mRNA degradation
(Behm-Ansmant et al., 2006). Thus, we cannot exclude that
CCR4-Not components affect additional mechanisms regulating
heart function. Importantly, our work on not3 in flies and mice
has also allowed us to identify a single-nucleotide polymorphism
in the human NOT3 promoter that is associated with prolonged
QT intervals and sudden cardiac death in humans. Thus, large-
scale screens in Drosophila can be directly translated toCell 141, 142–153, April 2, 2010 ª2010 Elsevier Inc. 151
mammalian species and, in combination with other genome-
wide approaches, can reveal regulators of heart function and
heart failure.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Extended Experimental
Procedures.
Fly Stocks
All RNAi transgenic fly lines were obtained from the Vienna Drosophila RNAi
Center (VDRC) RNAi stocks (Dietzl et al., 2007). The cardiac tissue-specific
TinCD4 12a-Gal4 was a kind gift from Manfred Frasch, (Lo and Frasch,
2001) and Hand-Gal4 was a gift from Eric Olsen (Han and Olson, 2005).
Screening System
Transgenic RNAi males were crossed to TinCD4 virgin females. Viable lines
were then incubated at 29C for 6 days to expose flies to temperature stress
(Paternostro et al., 2001). Initially, a Z score cutoff of 2 (mean control-test)/
SD was used to select RNAi lines for retesting.
Drosophila Cardiac Function, Morphology, and Gene Expression
UAS-RNAi fly lines obtained from the Vienna Drosophila RNAi Center were
crossed to Hand-Gal4 (II) driver flies and to w1118 wild-type control flies. Flies
were assessed for heart morphology and physiology with high-speed digital
video imaging (Ocorr et al., 2007b). M modes were generated and cardiac
parameters including heart periods, diastolic and systolic diameters, and frac-
tional shortening were recorded for each group with a MatLab-based image
analysis program (Fink et al., 2009). Fluorescent imaging of Drosophila heart
tubes was performed as described (Alayari et al., 2009).
Bioinformatics Analysis
For a detailed description of full bioinformatics analysis, please see the
Extended Experimental Procedures.
Phenotyping of not3 Knockout Mice
A targeting vector was constructed to replace exons 2 and 9 of the murine not3
gene. Fractional shortening (FS) was calculated as follows: FS = [(LVEDD –
LVESD)/LVEDD] 3 100. For ex vivo heart studies, hearts were assayed with
a Langendorff apparatus. The heart was paced electrically at 400 beats/min
(bpm), and the electrical field stimulation (EFS) was applied in conjunction
with the pacing stimulation. Isoproterenol was perfused for 30 s with the indi-
cated doses. For HDAC inhibition, wild-type and not3+/– mice were treated
with vehicle, Trichostatin A (TSA), or Valproic acid (VPA) for 1 week. Acid-
extracted histones were prepared, resolved, and transferred to nitrocellulose
membranes for western blotting. Transverse aorta constriction (TAC) was per-
formed as described (Kuba et al., 2007). For heart histology, hearts were
arrested, fixed, embedded in paraffin, and stained with hematoxylin and eosin
(H&E) or Masson-Trichrome.
Human QT Interval Association
Human QT interval association signals over the NOT3 region were obtained
from data generated by the QTSCD Consortium (Pfeufer et al., 2009).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, five tables, and one movie and can be found with this article online
at doi:10.1016/j.cell.2010.02.023.
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